SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
SEC Accession No. 0001047469-99-022642
Filing Date
1999-05-28
Accepted
1999-05-28 00:00:00
Documents
1
Group Members
BIOTECHNOLOGY VALUE FUND L PBIOTECHNOLOGY VENTURE PARTNERS LPBVF INCBVF PARTNERS LP

Document Format Files

Seq Description Document Type Size
1 SC 13D/A SC 13D/A 24130
  Complete submission text file 0001047469-99-022642.txt   26250
Mailing Address 117 FOURTH AVE NEEDHAM MA 02194
Business Address 117 FOURTH AVE NEEDHAM MA 02194 7814499560
REPLIGEN CORP (Subject) CIK: 0000730272 (see all company filings)

IRS No.: 042729386 | State of Incorp.: DE | Fiscal Year End: 0331
Type: SC 13D/A | Act: 34 | File No.: 005-38071 | Film No.: 99637913
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address 227 W MONROE STREET, SUITE 4800 227 W MONROE STREET, SUITE 4800 CHICAGO IL 60606
Business Address 227 W MONROE STREET, SUITE 4800 227 W MONROE STREET, SUITE 4800 CHICAGO IL 60606
BIOTECHNOLOGY VALUE FUND L P (Filed by) CIK: 0000918923 (see all company filings)

IRS No.: 363924731 | State of Incorp.: DE
SIC: 6282 Investment Advice